Dec 2, 2023 | Antithrombotics
1b) With the burgeoning #AFib population worldwide, effective #SPAF is hindered by #adherence issues, #underprescribing, & #underdosing. Meanwhile #cancer-assoc'd #thrombosis #CAT remains a challenge w/ debates over whether we are underestimating risk of...
Nov 28, 2023 | Arrhythmia
2) .@SeguraCardio is discussing "Clinical Trial Data Review & Clinical Applications for Class III #Antiarrhythmic Therapeutics for Pts with #AFib." Don't miss the previous installment on this topic (still available for🆓CE/#CME) at...
Nov 12, 2023 | Antithrombotics
2) Yes, #ChristianRuffMD just left the podium and we have MUCH to discuss in this LIVE program from #AHA23. Our guest author is Sid Patel MD @SidPatelMD, #Cardiology & #CriticalCare @BrighamFellows @HarvardMed & Research Fellow @TIMIStudyGroup....
Nov 11, 2023 | Arrhythmia
1b) That #EHRA affiliation is 🔑to today's program, as we focus on #AFib with rapid ventricular response #RVR. Atrial fibrillation with RVR leads to loss of atrial kick, shortened ventricular filling time, and increased #myocardial oxygen demand....